Nobivac NXT canine Influenza (flu H3N2) 0.5 ml/Dose 25 x 0.5 ml
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
Canine Influenza vaccine H3, RNA particle. Adjuvant, preservative, antibiotic, and thimerosal-free. Nobivac® NXT Canine Flu H3N2 is a non-adjuvanted, freeze-dried injectable canine influenza virus H3N2 vaccine, utilizing RNA particle technology. The vaccine stimulates expression of the desired antigen to induce a protective immune response against canine influenza virus H3N2. This product has been shown to be effective for the vaccination of healthy dogs 8 weeks of age or older against canine influenza virus H3N2. Duration of immunity has not been established.
Product Details
| Approved For | Dog |
| Therapeutic Use | Vaccine |
| Form | Powder for solution |
| Route of Administration | Subcutaneous |
| Strength / Concentration | 0.5 ml/Dose ml/Dose |
| Pack Size | 25 x 0.5 ml |
Safety & Storage
Storage: Refrigerated
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Merck |
|---|---|
| Strength | 0.5 ml/Dose ml/Dose |
| Pack Size | 25 x 0.5 ml |
Storage & Shipping
| Shipping Weight | 0.28 kg |
|---|---|
| Storage Conditions | Refrigerated |
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.
